Evidence map›Paper›PMID 37315143›Full record

ArticleScience advances2023

Not so smart? "Smart" drugs increase the level but decrease the quality of cognitive effort.

Elizabeth Bowman, David Coghill, Carsten Murawski, Peter Bossaerts

Abstract read
In one paragraph

Article in Science advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Article
  3. [Performance-related substance use in everyday life and work].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Seasonal trends in methylphenidate use: A mirror of misuse or compliance?The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa · 2025
    Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elizabeth BowmanCentre for Brain, Mind, and Markets, University of Melbourne, Parkville, Victoria 3010, Australia.ORCID 0000-0002-6876-6446
David CoghillDepartments of Paediatrics and Psychiatry, University of Melbourne, Parkville, Victoria 3010, Australia.ORCID 0000-0003-3017-9737
Carsten MurawskiCentre for Brain, Mind, and Markets, University of Melbourne, Parkville, Victoria 3010, Australia.ORCID 0000-0002-1237-9535
Peter BossaertsFaculty of Economics, University of Cambridge, Cambridge CB3 9DD, UK.ORCID 0000-0003-2308-2603

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The efficacy of pharmaceutical cognitive enhancers in everyday complex tasks remains to be established. Using the knapsack optimization problem as a stylized representation of difficulty in tasks encountered in daily life, we discover that methylphenidate, dextroamphetamine, and modafinil cause knapsack value attained in the task to diminish significantly compared to placebo, even if the chance of finding the optimal solution (~50%) is not reduced significantly. Effort (decision time and number of steps taken to find a solution) increases significantly, but productivity (quality of effort) decreases significantly. At the same time, productivity differences across participants decrease, even reverse, to the extent that above-average performers end up below average and vice versa. The latter can be attributed to increased randomness of solution strategies. Our findings suggest that "smart drugs" increase motivation, but a reduction in quality of effort, crucial to solve complex problems, annuls this effect.

Indexed as

Central Nervous System StimulantsCognitionMotivationHumansMethylphenidateModafinilCentral Nervous System StimulantsMethylphenidateModafinil

Identifiers

PMID37315143
PMCPMC10266726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.